Teva Pharmaceutical Industries | TEVA


Peers Price Chg Day Year Date
Sh Fosun Pharma 30.19 0.86 2.93% 34.12% Sep/05
Jiangsu Hengrui 72.47 3.82 5.56% 63.22% Sep/05
Guangzhou Baiy 26.48 0.09 0.34% 0.72% Sep/05
Aspen Pharmacare 10,393.00 113.00 1.10% -47.85% Sep/05
Cipla 1,553.40 -24.40 -1.55% -3.58% Sep/05
Dr.Reddys Laboratories 1,268.10 15.10 1.21% -4.90% Sep/05
Kalbe Farma 1,180.00 0 0% -30.18% Sep/04
Richter Gedeon 10,270.00 -160.00 -1.53% -3.11% Sep/05
Sun Pharmaceuticals 1,593.60 11.30 0.71% -12.66% Sep/05
Teva Pharmaceutical Industries 6,275.00 -65.00 -1.03% -9.12% Sep/04


Teva Pharmaceutical Industries Ltd traded at 6,275.00 this Thursday September 4th, decreasing 65.00 or 1.03 percent since the previous trading session. Looking back, over the last four weeks, Teva Pharmaceutical Industries lost 14.59 percent. Over the last 12 months, its price fell by 9.12 percent. Looking ahead, we forecast Teva Pharmaceutical Industries Ltd to be priced at 6,231.08 by the end of this quarter and at 6,101.14 in one year, according to Trading Economics global macro models projections and analysts expectations.

Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.